Stocktoria
EASTMAN CHEMICAL CO EMN
NYSE · stock · Plastic Materials, Synth Resins & Nonvulcan Elastomers · website · IPO 1993-12-14 · LEI
EASTMAN CHEMICAL CO financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.8B | $9.4B | $9.2B | $10.6B | $10.5B | $8.5B | $9.3B | $10.2B | $9.5B | $9.0B |
| Gross profit | $1.8B | $2.3B | $2.1B | $2.1B | $2.5B | $2.0B | $2.2B | $2.5B | $2.4B | $2.4B |
| R&D expense | $255.0M | $250.0M | $239.0M | $264.0M | $254.0M | $226.0M | $234.0M | $235.0M | $227.0M | $223.0M |
| SG&A expense | $658.0M | $736.0M | $727.0M | $726.0M | $795.0M | $654.0M | $691.0M | $721.0M | $729.0M | $707.0M |
| Operating income | — | — | — | — | — | — | — | — | $1.5B | $1.4B |
| Income tax | $93.0M | $170.0M | $191.0M | $181.0M | $215.0M | $41.0M | $140.0M | $226.0M | -$99.0M | $190.0M |
| Net income | $474.0M | $905.0M | $894.0M | $793.0M | $857.0M | $478.0M | $759.0M | $1.1B | $1.4B | $854.0M |
| EPS (diluted) | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 | $5.48 | $7.56 | $9.47 | $5.75 |
| Operating cash flow | $970.0M | $1.3B | $1.4B | $975.0M | $1.6B | $1.5B | $1.5B | $1.5B | $1.7B | $1.4B |
| Free cash flow | $424.0M | $688.0M | $546.0M | $364.0M | $1.1B | $1.1B | $1.1B | $1.0B | $1.0B | $759.0M |
| Cash & equivalents | $566.0M | $837.0M | $548.0M | $493.0M | $459.0M | $564.0M | $204.0M | $226.0M | $191.0M | $181.0M |
| Inventory | $2.0B | $2.0B | $1.7B | $1.9B | $1.5B | $1.4B | $1.7B | $1.6B | $1.5B | $1.4B |
| Total assets | $14.9B | $15.2B | $14.6B | $14.7B | $15.5B | $16.1B | $16.0B | $16.0B | $16.0B | $15.5B |
| Total liabilities | $8.8B | $9.4B | $9.1B | $9.4B | $9.7B | $10.0B | $10.0B | $10.1B | $10.5B | $10.8B |
| Shareholders' equity | $6.0B | $5.9B | $5.5B | $5.2B | $5.8B | $6.1B | $6.0B | $5.9B | $5.5B | $4.6B |
Growth · year-over-year · Revenue CAGR -0.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -6.7% | +1.9% | -12.9% | +1.0% | +23.6% | -8.6% | -8.6% | +6.3% | +6.0% | -6.6% |
| Net income growth | -47.6% | +1.2% | +12.7% | -7.5% | +79.3% | -37.0% | -29.7% | -22.0% | +62.1% | +0.7% |
| EPS growth | -46.5% | +2.4% | +18.0% | +1.6% | +78.6% | -36.1% | -27.5% | -20.2% | +64.7% | +1.6% |
| Free cash flow growth | -38.4% | +26.0% | +50.0% | -65.8% | -0.7% | -0.6% | +6.3% | +0.7% | +32.8% | -21.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.